Skip to main content
SpringerLink
Log in

Molecular Basis of Specificity in Nucleic Acid-Drug Interactions

Proceedings of the Twenty-Third Jerusalem Symposium on Quantum Chemistry and Biochemistry Held in Jerusalem, Israel, May 14–17, 1990

  • Conference proceedings
  • © 1990

Overview

Editors:
  1. Bernard Pullman

    1. Institut de Biologie Physico-Chimique (Fondation Edmond de Rothschild), Paris, France

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  2. Joshua Jortner

    1. Department of Chemistry, University of Tel-Aviv, Israel

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

Part of the book series: Jerusalem Symposia (JSQC, volume 23)

This is a preview of subscription content, log in via an institution to check access.

Access this book

Log in via an institution
eBook USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (37 papers)

  1. Front Matter

    Pages i-x
    Download chapter PDF

  2. Mutual Conformational Adaptation of Both Ligand and Receptor in Antitumor Drug-DNA Complexes

    • Andrew H.-J. Wang, Yen-Chywan Liaw, Howard Robinson, Yi-Gui Gao
    Pages 1-21

  3. DNA Drug Interactions Studied with Polarized Light Spectroscopy: The DAPI Case

    • B. Nordén, S. Eriksson, S. K. Kim, M. Kubista, R. Lyng, B. Åkerman
    Pages 23-41

  4. Drug-DNA Recognition: Sequence-Specificity of the DNA Minor Groove Binder Berenil

    • S. Neidle, D. G. Brown, T. C. Jenkins, C. A. Laughton, M. R. Sanderson, J. V. Skelly
    Pages 43-57

  5. Binding of Minor Groove Ligands to Short DNA Segments: Berenil Complexed with d(GCAATTGC)2 and d(GCTTAAGC)2

    • Richard H. Shafer, Mitsuru Yoshida, Debra L. Banville, Sungho Hu
    Pages 59-65

  6. The sequence specificity of damage caused by [125I]-labelled Hoechst 33258 and UV / iodoHoechst 33258 in intact cells and in cloned sequences of purified DNA which differ by a small number of base substitutions

    • Vincent Murray
    Pages 67-73

  7. Structure and Dynamics of a [1:1] Drug-DNA Complex: Analysis of 2D NMR Data Using Molecular Mechanics and Molecular Dynamics Calculations

    • Ramaswamy H. Sarma, Mukti H. Sarma, Kimiko Umemoto, Goutam Gupta, Angel E. Garcia
    Pages 75-93

  8. Determination of Distamycin-A Binding Modes by NMR

    • D. E. Wemmer, P. Fagan, J. G. Pelton
    Pages 95-101

  9. Molecular Mechanisms of DNA Sequence Recognition by Groove Binding Ligands: Biochemical and Biological Consequences

    • J. William Lown
    Pages 103-122

  10. Daunomycin Binding to DNA: From the Macroscopic to the Microscopic

    • Jonathan B. Chaires
    Pages 123-136

  11. In Vitro Transcription Analysis of the Sequence Specificity of Reversible and Irreversible Complexes of Adriamycin with DNA

    • D. R. Phillips, C. Cullinane, H. Trist, R. J. White
    Pages 137-155

  12. Quantitative Footprinting Analysis of the Actinomycin D-DNA Interaction

    • Robert Rehfuss, Jerry Goodisman, James C. Dabrowiak
    Pages 157-166

  13. Structural Requirements for DNA Topoisomerase II Inhibition by Anthracyclines

    • G. Capranico, F. Zunino
    Pages 167-176

  14. Thermodynamic Studies of Amsacrine Antitumor Agents with Nucleic Acids

    • D. E. Graves, R. M. Wadkins
    Pages 177-189

  15. Kinetic and Equilibrium Binding Studies of a Series of Intercalating Agents That Bind by Threading a Sidechain through the DNA Helix

    • Laurence P. G. Wakelin, William A. Denny
    Pages 191-206

  16. Aminoacyl-Anthraquinones: DNA-Binding and Sequence Specificity

    • Manlio Palumbo, Barbara Gatto
    Pages 207-224

  17. The Molecular Basis of Specific Recognition between Echinomycin and DNA

    • M. J. Waring
    Pages 225-245

  18. Bis-Pyrrolecarboxamides Linked to Intercalating Chromophore Oxazolopyridocarbazole (OPC): Properties Related to the Selective Binding to DNA at Rich Sequences

    • C. Auclair, F. Subra, D. Mrani, G. Gosselin, J. L. Imbach, C. Paoletti
    Pages 247-260

  19. Parallel-Stranded Nucleic Acids and Their Interaction with Intercalating and Groove Binding Drugs

    • Johan H. van de Sande, Bernd W. Kalisch, Markus W. Germann
    Pages 261-274

  20. Design of Bifunctional Nucleic Acid Ligands

    • T. Montenay-Garestier, J. S. Sun, J. Chomilier, J. L. Mergny, M. Takasugi, U. Asseline et al.
    Pages 275-290
Back to top

Keywords

About this book

One of the central problems in the study of the mechanism of DNA-ligand interactions is the existence and nature of sequence specificity with respect to the base pairs of DNA. The presence of such a specificity could be of particular significance because it might possibly mean the involvement of specific genes in the effectiveness of the different drugs. The elucidation of the factors responsible for the specificity could then be important for the development of compounds susceptible to contribute to the control of gene expression and also to the development of rationally conceived, improved new generations of effective and specific chemotherapeutic agents. Important recent achievements, experimental and theoretical, in the analysis of such sequence specificities open prospects for possible rapid progress in this field. The 23rd Jerusalem symposium was devoted to the exploration of these recent achievements in relation to many types of ligand, with special emphasis on antitumor drugs. All major types of interaction, intercalation, groove binding, covalent linking, coordination, have been considered. So was also the effect of the interaction on the structure and properties of the nucleic acids and the relationship between the interaction and biological or pharmacological activities. We feel that this Volume presents a relatively complete up-to-date account of the state of the art in this important field of research.

Editors and Affiliations

  • Institut de Biologie Physico-Chimique (Fondation Edmond de Rothschild), Paris, France

    Bernard Pullman

  • Department of Chemistry, University of Tel-Aviv, Israel

    Joshua Jortner

Bibliographic Information

  • Book Title: Molecular Basis of Specificity in Nucleic Acid-Drug Interactions

  • Book Subtitle: Proceedings of the Twenty-Third Jerusalem Symposium on Quantum Chemistry and Biochemistry Held in Jerusalem, Israel, May 14–17, 1990

  • Editors: Bernard Pullman, Joshua Jortner

  • Series Title: Jerusalem Symposia

  • DOI: https://doi.org/10.1007/978-94-011-3728-7

  • Publisher: Springer Dordrecht

  • eBook Packages: Springer Book Archive

  • Copyright Information: Springer Science+Business Media Dordrecht 1990

  • Hardcover ISBN: 978-0-7923-0897-3Published: 31 October 1990

  • Softcover ISBN: 978-94-010-5657-1Published: 29 October 2012

  • eBook ISBN: 978-94-011-3728-7Published: 06 December 2012

  • Series ISSN: 0924-4875

  • Edition Number: 1

  • Number of Pages: X, 603

  • Topics: Biochemistry, general, Medical Biochemistry

Publish with us

Policies and ethics

Back to top

Search

Navigation